TGF-β signaling in renal disease

Journal of the American Society of Nephrology

Volumn 13, Issue 10, 2002, Pages 2600-2610

  Böttinger, Erwin P ^a   Bitzer, Markus ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SMAD PROTEIN; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CAPILLARY ENDOTHELIUM; CELL DIFFERENTIATION; CHRONIC KIDNEY DISEASE; DISEASE COURSE; EPITHELIUM CELL; GENE TARGETING; GLOMERULUS EPITHELIUM; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY EPITHELIUM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036786834     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000033611.79556.AE     Document Type: Review

References (99)

1. Wolfe RA, Port FK, Webb RL, Bloembergen WE, Hirth R, Young EW, Ojo AO, Strawderman RL, Parekh R, Stack A, Tedeschi PJ, Hulbert-Shearon T, Ashby VB, Callard S, Hanson J, Jain A, Meyers-Purkiss A, Roys E, Brown P, Wheeler JR, Jones CA, Greer JW, Agodoa LY: Introduction to the excerpts from the United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis 34: S1-S3, 1999
2. Border WA, Okuda S, Languino LR, Ruoslahti E: Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int 37: 689-695, 1990
3. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346: 371-374, 1990
4. Border WA, Okuda S, Nakamura T, Languino LR, Ruoslahti E: Role of TGF-beta 1 in experimental glomerulonephritis. Ciba Found Symp 157:178-89; discus, 1991
5. Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kurnik BRC, Kurnik PB, Weisberg LS: Increased renal production of transforming growth factor-b1 in patients with type II diabetes mellitus. Diabetes 46:854-859, 1997
6. Ziyadeh FN: Role of transforming growth factor beta in diabetic nephropathy. Exp Nephrol 2:137, 1994
7. Bitzer M, Sterzel RB, Bottinger EP: Transforming growth factor-beta in renal disease. Kidney Blood Press Res 21:1-12, 1998
8. Massague J: How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1:169-178, 2000
9. Roberts AB, Sporn MB: The transforming growth factors-β. In: Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors., 95 edn., edited by Sporn MB, Roberts AB, Berlin Heidelberg New York London Paris Tokyo Hong Kong, Springer-Verlag, 1990, p 419-472.
10. Roberts AB: Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24:111-119, 1998
11. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, Piek E, Bottinger EP: Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci U.S.A 98:6686-6691, 2001
12. Roberts AB: The ever-increasing complexity of TGF-beta signaling. Cytokine Growth Factor Rev 13:3-5, 2002
13. ten Dijke P, Goumans MJ, Itoh F, Itoh S: Regulation of cell proliferation by Smad proteins. J Cell Physiol 191:1-16, 2002
14. Derynck R, Akhurst RJ, Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29:117-129, 2001
15. Massague J, Chen YG: Controlling TGF-beta signaling. Genes Dev 14:627-644, 2000
16. Rennke HG, Anderson S, Brenner BM: The progression of renal disease: structural and functional correlations. In: Renal Pathology edited by Tisher CC, Brenner BM, Philadelphia, J.B. Lippincott Company, 1994, pp 116-150
17. Harris DC: Tubulointerstitial renal disease. Curr Opin Nephrol Hypertens 10:303-313, 2001
18. Bohle A, Wehrmann M, Bogenschutz O, Batz C, Vogl W, Schmitt H, Muller CA, Muller GA: The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol Res Pract 188:908-924, 1992
19. Fine LG, Orphanides C, Norman JT: Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl 65:S74-S78, 1998
20. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997
21. Burton C, Harris KP: The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 27:765-775, 1996
22. Johnson RJ: Cytokines, growth factors and renal injury: where do we go now? Kidney Int Suppl 63:S2-S6, 1997
23. Wu LL, Cox A, Roe CJ, Dziadek M, Cooper ME, Gilbert RE: Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system. Kidney Int 51:1553-1567, 1997
24. Eddy AA: Molecular basis of renal fibrosis. Pediatr Nephrol 15:290-30, 2000
25. Kriz W, Gretz N, Lemley KV: Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 54:687-697, 1998
26. Lee LK, Meyer TW, Pollock AS, Lovett DH: Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 96:953-964, 1995
27. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ: Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13:806-816, 2002
28. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ: Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12:1448-1457, 2001
29. Meyer TW, Bennett PH, Nelson RG: Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 42:1341-1344, 1999
30. Border WA, Noble NA: TGF-beta in kidney fibrosis: a target for gene therapy. [Review] [40 refs]. Kidney Int 51:1388-1396, 1997
31. Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A: Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6:1183-1186, 2000
32. Sgonc R: The vascular perspective of systemic sclerosis: of chickens, mice and men. Int Arch Allergy Immunol 120:169-176, 1999
33. Tuan TL, Nichter LS: The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4:19-24, 1998
34. Lieubeau B, Garrigue L, Barbieux I, Meflah K, Gregoire M: The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development. Cancer Res 54:6526-6532, 1994
35. Gobe GC, Axelsen RA: Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis. Lab Invest 56:273-281, 1987
36. Ito H, Kasagi N, Shomori K, Osaki M, Adachi H: Apoptosis in the human allografted kidney. Analysis by terminal deoxynucleotidyl transferase-mediated DUTP-botin nick end labeling. Transplantation 60:794-798, 1995
37. Ortiz A, Ziyadeh FN, Neilson EG: Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J Investig Med 45:50-56, 1997
38. Kelly DJ, Cox AJ, Tolcos M, Cooper ME, Wilkinson-Berka JL, Gilbert RE: Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int 61: 31-39, 2002
39. Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED, Felsen D: Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58:2301-2313, 2000
40. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS: Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U.S.A. 92:2572-2576, 1995
41. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS: Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 74:991-1003, 1996
42. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405, 1995
43. Strutz F, Muller GA, Neilson EG: Transdifferentiation: a new angle on renal fibrosis. [Review] [32 refs]. Experimental Nephrology 4:267-270, 1996
44. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic-Paterson DJ, Atkins RC, Lan HY: Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 54:864-876, 1998
45. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, Strutz F, Muller GA, Colasanti G, D'Amico G: Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 62:137-146, 2002
46. Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P: TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 112 (Pt 24):4557-4568, 1999
47. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL: Phosphatidylinositol-3 Kinase Function is Required for TGFβ-mediated Epithelial to Mesenchymal Transition and Cell Migration. J Biol Chem 2000
48. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Muller GA, Neilson EG: Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 61:1714-1728, 2002
49. Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME: Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108:1853-1863, 2001
50. Mundel P, Schwarz K, Reiser J: Podocyte biology: a footstep further. Adv Nephrol Necker Hosp 31:235-241, 2001
51. Petermann AT, Hiromura K, Blonski M, Pippin J, Monkawa T, Durvasula R, Couser WG, Shankland SJ: Mechanical stress reduces podocyte proliferation in vitro. Kidney Int 61:40-50, 2002
52. Shankland SJ: Cell-cycle control and renal disease. Kidney Int 52:294-308, 1997
53. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, Bottinger EP: Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108:807-816, 2001
54. Shih NY, Li J, Karpitskii V, Nguyen A, Dustin ML, Kanagawa O, Miner JH, Shaw AS: Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286:312-315, 1999
55. Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am J Pathol 151:1231-1239, 1997
56. Kitamura H, Shimizu A, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant-kidney model. Exp Nephrol 6:328-336, 1998
57. Ohashi R, Kitamura H, Yamanaka N: Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol 11:47-56, 2000
58. Guo N, Krutzsch HC, Inman JK, Roberts DD: Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 57:1735-1742, 1997
59. Choi ME, Ballermann BJ: Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-beta receptors. J Biol Chem 270:21144-21150, 1995
60. Simon M, Grone HJ, Johren O, Kullmer J, Plate KH, Risau W, Fuchs E: Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am J Physiol 268:F240-F250, 1995
61. Berse B, Brown LF, van de WL, Dvorak HF, Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211-220, 1992
62. Miettinen PJ, Ebner R, Lopez AR, Derynck R: TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 127:2021-2036, 1994
63. Portella G, Cumming SA, Liddell J, Cui W, Ireland H, Akhurst RJ, Balmain A: Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ 9:393-404, 1998
64. Strutz F, Muller GA, Neilson EG: Transdifferentiation: a new angle on renal fibrosis. Exp Nephrol 4:267-270, 1996
65. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY: Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56:1455-1467, 1999
66. Shen X, Li J, Hu PP, Waddell D, Zhang J, Wang XF: The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J Biol Chem 276:15362-15368, 2001
67. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL: Transforming Growth Factor-beta1 Mediates Epithelial to Mesenchymal Transdifferentiation through a RhoA-dependent Mechanism. Mol Biol Cell 12: 27-36, 2001
68. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F: The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7:1267-1278, 2001
69. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC: Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46, 1992
70. Coles HS, Burne JF, Raff MC: Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118:777-784, 1993
71. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota A: Apoptosis in glomerular sclerosis. Kidney Int 49:103-111, 1996
72. Wagrowska-Danilewicz M, Danilewicz M: A study of apoptosis in human glomerulonephritis as determined by in situ nonradioactive labelling of DNA strand breaks. Acta Histochem 99:257-266, 1997
73. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota A: Apoptosis in glomerular sclerosis. Kidney Int 49:103-111, 1996
74. Wagrowska-Danilewicz M, Danilewicz M: A study of apoptosis in human glomerulonephritis as determined by in situ nonradioactive labelling of DNA strand breaks. Acta Histochem 99:257-266, 1997
75. Schuster N, Krieglstein K: Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res 307:1-14, 2002
76. Ten Dijke P, Goumans MJ, Itoh F, Itoh S: Regulation of cell proliferation by Smad proteins. J Cell Physiol 191:1-16, 2002
77. Yanagisawa K, Osada H, Masuda A, Kondo M, Saito T, Yatabe Y, Takagi K, Takahashi T, Takahashi T: Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells. Oncogene 17:1743-1747, 1998
78. Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH: TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nat Cell Biol 4:51-58, 2002
79. Chalaux E, Lopez-Rovira T, Rosa JL, Pons G, Boxer LM, Bartrons R, Ventura F: A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett. 457:478-482, 1999
80. Ribeiro A, Bronk SF, Roberts PJ, Urrutia R, Gores GJ: The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress. Hepatology 30:1490-1497, 1999
81. Ohta S, Yanagihara K, Nagata K: Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor beta. Biochem J 324 (Pt 3):777-782, 1997
82. Kim BC, Mamura M, Choi KS, Calabretta B, Kim SJ: Transforming growth factor beta 1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells. Mol Cell Biol 22:1369-1378, 2002
83. Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA: TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol 3:708-714, 2001
84. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K: Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270:2008-2011, 1995
85. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K: TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science 272:1179-1182, 1996
86. Wang W, Zhou G, Hu MC, Yao Z, Tan TH: Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction. J Biol Chem 272: 22771-22775, 1997
87. Mazars A, Lallemand F, Prunier C, Marais J, Ferrand N, Pessah M, Cherqui G, Atfi A: Evidence for a role of the JNK cascade in Smad7-mediated apoptosis. J.Biol.Chem. 276:36797-36803, 2001
88. Landstrom M, Heldin NE, Bu S, Hermansson A, Itoh S, Dijke P, Heldin CH: Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells. Curr Biol 10: 535-538, 2000
89. Lallemand F, Mazars A, Prunier C, Bertrand F, Kornprost M, Gallea S, Roman-Roman S, Cherqui G, Atfi A: Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene 20:879-884, 2001
90. von Gersdorff G, Susztak K, Rezvani F, Bitzer M, Liang D, Bottinger EP: Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta. J Biol Chem 275:11320-11326, 2000
91. Topper JN, Cai J, Qiu Y, Anderson KR, Xu YY, Deeds JD, Feeley R, Gimeno CJ, Woolf EA, Tayber O, Mays GG, Sampson BA, Schoen FJ, Gimbrone MA, Jr., Falb D: Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci U.S.A 94:9314-9319, 1997
92. Ulloa L, Doody J, Massague J: Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397:710-713, 1999
93. Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, ttinger EP: A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappaB/RelA. Genes Dev 14: 187-197, 2000
94. Larisch S, Yi Y, Lotan R, Kerner H, Eimerl S, Tony PW, Gottfried Y, Birkey RS, de Caestecker MP, Danielpour D, Book-Melamed N, Timberg R, Duckett CS, Lechleider RJ, Steller H, Orly J, Kim SJ, Roberts AB: A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif. Nat Cell Biol 2:915-921, 2000
95. Motyl T, Grzelkowska K, Zimowska W, Skierski J, Wareski P, Ploszaj T, Trzeciak L: Expression of bcl-2 and bax in TGF-beta 1-induced apoptosis of L1210 leukemic cells. Eur J Cell Biol 75:367-374, 1998
96. Francis JM, Heyworth CM, Spooncer E, Pierce A, Dexter TM, Whetton AD: Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells. J Biol Chem 275: 39137-39145, 2000
97. Chipuk JE, Bhat M, Hsing AY, Ma J, Danielpour D: Bcl-xL blocks transforming growth factor-beta 1-induced apoptosis by inhibiting cytochrome c release and not by directly antagonizing Apaf-1-dependent caspase activation in prostate epithelial cells. J Biol Chem 276:26614-26621, 2001
98. Schnaper HW, Hayashida T, Poncelet AC: It's a Smad World: Regulation of TGF-beta Signaling in the Kidney. J Am Soc Nephrol 13:1126-1128, 2002
99. Verrecchia F, Mauviel A: Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis. Curr Rheumatol Rep 4:143-149, 2002